Speakers

These successful investors, innovators and executives will share insights on identifying, funding and advancing new therapies that will transform the treatment of respiratory diseases.

Bernard Coulie

Bernard Coulie, MD, PhD

President & CEO
Pliant Therapeutics

Cayce Denton

Director
Temasek
James Eadie

James Eadie

Partner
Santé Ventures
Erik Folch

Erik Folch

Chief, Complex Chest Disease Center
Massachusetts General Hospital, Harvard Medical School
Jeffrey Goldstein

Jeffrey Goldstein

President
Lung Transplant Foundation
Cecelia Gonzalo

Cecilia Gonzalo

Partner
Oberland Capital
Charles

Charles Hamilton

Director
Piper Jaffray
Chris Hogg

Chris Hogg

Chief Commercial Officer
Propeller Health
C. Matthew Kinsey

C. Matthew Kinsey, MD, MPH

Director, Interventional Pulmonary
University of Vermont
Ben Kramer

Benjamin Kramer, MD

VP, Immunology & Ophthalmology, US Medical Affairs
Genentech
Polly Parsons

Polly Parsons

President
American Thoracic Society
Jason Pesterfield

Jason Pesterfield

President & CEO
Veran Medical Technologies
Jonathan Phillips

Jonathan Phillips

Principal Scientist
Amgen
Beran Rose

Beran Rose

VP, Marketing & Business Development
Pulmonx
Tom Salemi

Tom Salemi

Content Director
Healthegy
John Sheridan

John Sheridan

Director of Research
Cystic Fibrosis Foundation
Momen Wahidi

Momen Wahidi, MD, MBA

Director, Interventional Pulmonology and Bronchoscopy
Duke University Health System
Dennis Wahr

Dennis Wahr, MD

CEO
Nuvaira
Jonathan Waldstreicher

Jonathan Waldstreicher, MD, MBA

CEO / Principal
Gala Therapeutics / Apple Tree Partners
Simon Walsh

Simon Walsh

Cofounder / Founder
The Open Source Imagining Consortium / Euclidean Diagnostics
Tim Watkins

Timothy Watkins, MD, MSc

Executive Director, Clinical Research, Respiratory Disease Area Lead Inflammation/Respiratory Therapeutic Area
Gilead Sciences